Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Return on Equity: 2011-2018

Historic Return on Equity for EyePoint Pharmaceuticals (EYPT) over the last 7 years, with Sep 2018 value amounting to -1.17%.

  • EyePoint Pharmaceuticals' Return on Equity rose 39.00% to -1.17% in Q3 2018 from the same period last year, while for Sep 2018 it was -1.17%, marking a year-over-year increase of 39.00%. This contributed to the annual value of -4.25% for FY2018, which is 317.00% down from last year.
  • According to the latest figures from Q3 2018, EyePoint Pharmaceuticals' Return on Equity is -1.17%, which was up 55.86% from -2.64% recorded in Q2 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Return on Equity registered a high of 0.43% during Q3 2014, and its lowest value of -2.64% during Q2 2018.
  • Its 3-year average for Return on Equity is -1.60%, with a median of -1.38% in 2017.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Return on Equity soared by 162bps in 2014, and later plummeted by 142bps in 2015.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Return on Equity stood at 0.30% in 2014, then tumbled by 142bps to -1.12% in 2015, then fell by 16bps to -1.28% in 2016, then plummeted by 116bps to -2.44% in 2017, then soared by 39bps to -1.17% in 2018.
  • Its Return on Equity was -1.17% in Q3 2018, compared to -2.64% in Q2 2018 and -2.50% in Q1 2018.